Catarina O. White

Catarina O. White's work experience begins with their current role as the Director of Regulatory Strategy at Framework Solutions, LLC, which they started in May 2023. Prior to this, they were a Principal Consultant in Regulatory Affairs at Opus Regulatory Inc. from September 2021 to May 2023.

In 2021, Catarina also worked as the Associate Director of Regulatory Affairs at Taysha Gene Therapies from January to September. Before that, they held two positions at Axovant Gene Therapies, Ltd., serving as an Associate Director from April 2020 to January 2021, and as a Regulatory Affairs Manager from March 2019 to March 2020.

From 2016 to 2018, Catarina worked as a Senior Regulatory Affairs Associate and later as a Regulatory Affairs Consultant at Syneos Health (Previously INC Research/inVentiv Health). Prior to this, they held the position of Sr. Regulatory Associate at INC Research from September 2016 to January 2018.

Catarina's work experience also includes roles as a Research Fellow at UNC-Chemistry, where they led pharmacological development projects and conducted extensive research on depression, anxiety, and drug abuse from July 2010 to September 2016. Catarina also worked as a Postdoctoral fellow, successfully investigating the dopaminergic activity in addictive behaviors from 2005 to 2010.

Additionally, Catarina completed a Regulatory Affairs Internship at Duke Translational Medicine Institute (DTMI) from August 2015 to February 2016. Catarina started their career as a Medical Writer at NeuroInsights LLC, where they gained extensive knowledge of the medical industry and prepared newsletters on drug discovery and neurodegenerative disorders from November 2014 to February 2016.

Catarina completed their graduate studies as a Graduate student at Queen Mary, University of London from 1998 to 2002.

Catarina O. White has a strong educational background in the field of neuroscience. Catarina earned their Doctor of Philosophy (PhD) in Neuroscience from Queen Mary University of London from 1998 to 2002. Prior to that, they pursued their Master's degree in neuroscience from Lund University from 1993 to 1997.

In recent years, Catarina has expanded their expertise and knowledge by pursuing additional education in pharmacy administration and pharmacy policy and regulatory affairs. Currently, they are enrolled at the Duke Translational Medicine Institute (DTMI), Duke University Medical Center since 2015. Although the end year is not provided, Catarina is likely still actively pursuing their studies in this field.

Overall, Catarina O. White has a strong educational foundation in neuroscience, and they have continued to expand their knowledge in the field of pharmacy administration and policy through their ongoing studies at DTMI.